Cargando…

6-Valent Virus-Like Particle-Based Vaccine Induced Potent and Sustained Immunity Against Noroviruses in Mice

Norovirus is a major cause of acute gastroenteritis worldwide, and no vaccine is currently available. The genetic and antigenic diversity of Norovirus presents challenges for providing broad immune protection, which calls for a multivalent vaccine application. In this study, we investigated the poss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Wenli, Lv, Lihui, Wang, Yihan, Xing, Man, Guo, Yingying, Xie, Di, Wei, Xin, Zhang, Xiuyue, Liu, Hui, Ren, Jiling, Zhou, Dongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197435/ https://www.ncbi.nlm.nih.gov/pubmed/35711416 http://dx.doi.org/10.3389/fimmu.2022.906275

Ejemplares similares

Virus-like Particle Vaccines for Norovirus Gastroenteritis
por: Chen, Qiang
Publicado: (2013)

Modular vaccine platform based on the norovirus-like particle
por: Lampinen, Vili, et al.
Publicado: (2021)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Norovirus Vaccine: Priorities for Future Research and Development
por: Esposito, Susanna, et al.
Publicado: (2020)

Use of rabbit antibodies raised against Norovirus GII.4 virus-like particles for diagnosis of Norovirus infection
por: Kulkarni, Ruta, et al.
Publicado: (2017)

Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates
por: Xiao, Peng, et al.
Publicado: (2021)

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells
por: Liu, Xinlin, et al.
Publicado: (2023)

Potent anti-inflammatory activity of the lectin-like domain of TNF in joints
por: Pinto, Ana Carolina Matias Dinelly, et al.
Publicado: (2022)

Environmentally-triggered contraction of the norovirus virion determines diarrheagenic potential
por: Helm, Emily W., et al.
Publicado: (2022)

Secreted production of assembled Norovirus virus-like particles from Pichia pastoris
por: Tomé-Amat, Jaime, et al.
Publicado: (2014)

Norovirus-like VP1 particles exhibit isolate dependent stability profiles
por: Pogan, Ronja, et al.
Publicado: (2018)

N-terminal VP1 Truncations Favor T = 1 Norovirus-Like Particles
por: Pogan, Ronja, et al.
Publicado: (2020)

Human Norovirus Proteins: Implications in the Replicative Cycle, Pathogenesis, and the Host Immune Response
por: Campillay-Véliz, Claudia P., et al.
Publicado: (2020)

Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico
por: Wasserman, Matthew, et al.
Publicado: (2018)

Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection
por: Romaru, Juliette, et al.
Publicado: (2021)

Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine
por: Chen, Wei, et al.
Publicado: (2020)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
por: Gao, Yong, et al.
Publicado: (2018)

Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions
por: Pearson, James A., et al.
Publicado: (2019)

Bacterial extracellular vesicles control murine norovirus infection through modulation of antiviral immune responses
por: Bhar, Sutonuka, et al.
Publicado: (2022)

The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency
por: Robbins, Ailsa, et al.
Publicado: (2021)

Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands
por: Ettayebi, Khalil, et al.
Publicado: (2008)

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles
por: Huhti, L., et al.
Publicado: (2010)

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography
por: Huhti, L., et al.
Publicado: (2012)

Non-spherical gold nanoparticles enhanced fluorescence of carbon dots for norovirus-like particles detection
por: Alzahrani, Abdulhakeem, et al.
Publicado: (2023)

Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human
por: Gao, Fei, et al.
Publicado: (2019)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

The adjuvant effect of bacterium-like particles depends on the route of administration
por: Sudo, Haruka, et al.
Publicado: (2023)

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells
por: Watkinson, Fiona, et al.
Publicado: (2021)

Identification of a First Human Norovirus CD8(+) T Cell Epitope Restricted to HLA-A(*)0201 Allele
por: Malm, Maria, et al.
Publicado: (2018)

Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein
por: Ford-Siltz, Lauren A., et al.
Publicado: (2022)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

Bacterium-like particles derived from probiotics: progress, challenges and prospects
por: Zhou, Xinyao, et al.
Publicado: (2023)

Norovirus GII.4 Virus-like Particles Recognize Galactosylceramides in Domains of Planar Supported Lipid Bilayers**
por: Bally, Marta, et al.
Publicado: (2012)

Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles
por: Ponterio, Eleonora, et al.
Publicado: (2013)

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles
por: Malm, Maria, et al.
Publicado: (2016)

Crystallization and X-ray analysis of 23 nm virus-like particles from Norovirus Chiba strain
por: Hasegawa, Kazuya, et al.
Publicado: (2017)

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine
por: Ramani, Sasirekha, et al.
Publicado: (2017)

RNA Sequencing of Murine Norovirus-Infected Cells Reveals Transcriptional Alteration of Genes Important to Viral Recognition and Antigen Presentation
por: Enosi Tuipulotu, Daniel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jm8lka9lu3hl7r1q2cc6ia2re8